'Pharma lyophilisation Market Will Reach $2.48 billion in 2012' Predicts Visiongain Report

'Pharma lyophilisation Market Will Reach $2.48 billion in 2012' Predicts Visiongain Report PR Newswire LONDON, September 6, 2012 LONDON, September 6, 2012 /PRNewswire/ -- A new report by visiongain predicts that the 2012 world market for lyophilisation (freeze drying) products and services for pharma will reach $2.48 billion. That revenue forecast and others appear in Lyophilisation for Pharmaceuticals: Products and Services Market 2012-2022, published in September 2012. Visiongain is a business information provider based in London, UK. Visiongain predicts that pharmaceutical freeze drying revenues will increase strongly from 2012 to 2022, with many commercial opportunities for those products and services. Through emerging technologies and increasing demand for drugs using lyophilisation, the future of that industry and market holds great promise. Dr Syed Ahmed, a senior pharmaceutical industry analyst in visiongain, said: "In recent years the market for lyophilisation technology and services has enjoyed strong growth. Key drivers for the sector have been new products and drug classes, especially in biotechnology. We predict that industry and market will continue to expand through greater demand for lyophilisation technologies and services, particularly demand from the expanding industry for injectable therapeutics. "Our research shows that the world lyophilisation industry and market will benefit from the launch of new biologic drugs and vaccines.